IL-1 β and TNF-α produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C

Digestive Diseases and Sciences

Volumn 41, Issue 2, 1996, Pages 315-321

  Kishihara, Yasuhiro ^a   Hayashi, Jun ^a   Yoshimura, Eriko ^a   Yamaji, Kouzaburo ^a   Nakashima, Koya ^a   Kashiwagi, Seizaburo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; IL 1; Interferon therapy; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, VIRAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029871106     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02093821     Document Type: Article

References (28)

1. Arai K, Lee F, Miyajima A, Miyataka S, Argi N, Yokota T: Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biothem 59:783-836, 1990
2. Dinarello CA, Mier JW: Current concepts, lymphokines. N Engl J Med 317:940-945, 1987
3. Ozyilkun E, Tatar G, Hacibektasoglu A, Kayhan B, Telatar H: Impaired lipopolysaccharide-induced interleukin-1-beta production in patients with anti-hepatitis C virus antibody-positive chronic liver disease. Scand J Gastroenterol 29:280-283, 1994
4. Muller C, Knoflach P, Zielinski CC: Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis. Dig Dis Sci 38:477-481, 1993
5. Anastassakos C, Alexander GJM, Wolstencroft RA, Avery JA, Portmann BG, Panayi GS, Dumonde DC, Eddleston ALWF, Williams R: Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 94:999-1005, 1988
6. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M: Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 10:769-773, 1989
7. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992
8. Lazzari FD, Fabris P, Floreani A, Bortolami M, Venturi C, Chiaramonte M, Naccarato R: Tumor necrosis factor-alpha behavior in serum during recombinant-alpha-2b-interferon treatment of chronic viral hepatitis. Eur J Gastroenterol Hepatol 6:625-628, 1994
9. Daniels HM, Meager A, Eddelston ALWF, Alexander GJM, Williams R: Spontaneous production of tumor necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancer 335:875-877, 1990
10. Dinarello CA: Interleukin-1 and its biologically related cytokines. Adv Immunol 44:153-205, 1989
11. Oppenheim JJ, Kovaks EJ, Matsushima K, Durum SK: There is more than one interleukin I. Immunol Today 7:45-56, 1986
12. Scheurich P, Thoma B, Ucer U, Pfizenmaier K: Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: Induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 138:1786-1790, 1987
13. Wong GHW, Goeddel DV: Tumor necrosis alpha and beta inhibit virus replication and synergize with interferon. Nature 323:819-822, 1986
14. Mestan J, Digel W, Mittnacht S: Antiviral effects of recombinant tumor necrosis factor in vitro. Nature 323:816-819, 1986
15. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie AM, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 315:1575-1578, 1986
16. Hayashi J, Nakashima K, Noguichi A, Hirata M, Akazawa K, Kashiwagi S: Antiviral effect of interferon therapy for patients with chronic hepatitis C. Antiviral Chem Chemother 3:305-309, 1992
17. Hayashi J, Ohmiya M, Kishihara Y, Tani Y, Kinukawa N, Ikematsu H, Kashiwagi S: A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol 89:2151-2156, 1994
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R. Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435, 1981
19. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Satoh K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
20. Kaneko S, Murakami S, Unoura M, Kobayashi K: Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction. J Med Virol 37:278-282, 1992
21. Tanaka K, Ishikawa E, Ohmoto Y, Hirai Y: In vitro production of human interleukin 1α and interleukin 1β by peripheral blood mononuclear cells examined by sensitive sandwitch enzyme immunoassay. Eur J Immunol 17:1527-1530, 1989
22. Takehara T, Hayashi N, Mita E, Hagiwara H, Ueda K, Katayama K, Kasahara A, Fusamoto H, Kamada T: Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: Implications for hepatitis C virus replication in infected tissue. Hepatology 15:387-390, 1992
23. Deviere J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E: Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 11:628-634, 1990
24. Di Bisceglie A, Hoofnagle JH: Therapy of chronic hepatitis C with alpha-interferon: The answer? Or more questions? Hepatology 13:601-603, 1991
25. Camps J, Crisostomo S, Garcia-Granero M, Riezu-Boj JI, Civeira MP, Prieto J: Prediction of the response of chronic hepatitis C to interferon alpha: A statistical analysis of pretreatment variables. Gut 34:1714-1717, 1993
26. Noguchi A, Hayashi J, Nakashima K, Hirata M, Ikematsu H, Kashiwagi S: HBsAg subtypes among HBsAg carriers in Okinawa, Japan: Evidence of an important relationship in seroconversion from HBeAg to anti HBe. J Infect 28:141-150, 1994
27. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Jiraori T, Suzuki S: Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. Hepatology 18:1319-1325, 1993
28. Tilg H, Mier JW, Vogel W, Aulitzky WE, Wiedermann CJ, Vannier E, Huber C, Dinarello CA: Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol 150:4687-4692, 1993